Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization

China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-A Quality Control on Right Heart Catheterization

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Right heart catheterization(RHC) plays a crucial role in the diagnosis and treatment of pulmonary vascular diseases(PVD). In China, the lack of equipment and technical expertise has historically limited the implementation of RHC, thereby greatly restricting the diagnosis and treatment of RVD. In recent years, with improvements in these issues, more hospitals have acquired the capability to perform RHC. The purpose of this study is to conduct quality control of RHC across multiple pulmonary hypertension(PH) centers in China. The study population consists of patients who underwent RHC for the first time due to dyspnea or suspected PH. This study retrospectively and prospectively collects multicenter RHC data, with the main quality control contents including indications for the procedure, collection and analysis of hemodynamic data, diagnosis and treatment, and long-term management of patients.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients who underwent right heart catheterization for the first time due to dyspnea or suspected pulmonary hypertension - Age ≥14 years old Who Should NOT Join This Trial: - Vital data missing - Did not sign willing to sign a consent form or did not agree to follow-up Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients who underwent right heart catheterization for the first time due to dyspnea or suspected pulmonary hypertension * Age ≥14 years old Exclusion Criteria: * Vital data missing * Did not sign informed consent or did not agree to follow-up

Treatments Being Tested

OTHER

No intervention; Observational study

No intervention; observational study

Locations (1)

China-Japan Friendship Hospital
Beijing, China